T1	Participants 262 429	173 newly diagnosed multiple myeloma patients of etidronate disodium (EHDP), a diphosphonate compound that reduces bone resorption by inhibiting osteoclastic activity.
T2	Participants 1173 1189	Patients on EHDP
